Single agent of apatinib in patients with recurrent or refractory cervical cancer: A real-world multicenter retrospective study.
2019
e17011Background: Few effective treatment strategy has been established for patients with recurrent or refractory cervical cancer. The present study evaluates the efficacy and safety of apatinib si...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI